This article has Open Peer Review reports available.
Toremifene, a selective estrogen receptor modulator, significantly improved biochemical recurrence in bone metastatic prostate cancer: a randomized controlled phase II a trial
© Fujimura et al. 2015
Received: 16 July 2015
Accepted: 26 October 2015
Published: 2 November 2015
Open Peer Review reports
Pre-publication versions of this article are available by contacting firstname.lastname@example.org.
|16 Jul 2015||Submitted||Original manuscript|
|28 Jul 2015||Reviewed||Reviewer Report - Christian Ostheimer|
|31 Jul 2015||Reviewed||Reviewer Report - Zhanwei Wang|
|1 Sep 2015||Author responded||Author comments - Tetsuya Fujimura|
|Resubmission - Version 2|
|1 Sep 2015||Submitted||Manuscript version 2|
|16 Sep 2015||Reviewed||Reviewer Report - Zhanwei Wang|
|16 Oct 2015||Author responded||Author comments - Tetsuya Fujimura|
|Resubmission - Version 3|
|16 Oct 2015||Submitted||Manuscript version 3|
|26 Oct 2015||Editorially accepted|
|2 Nov 2015||Article published||10.1186/s12885-015-1871-z|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting email@example.com.
You can find further information about the peer review system here.